Cross Staff Investments Inc Bristol Myers Squibb CO Transaction History
Cross Staff Investments Inc
- $128 Million
- Q1 2025
A detailed history of Cross Staff Investments Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cross Staff Investments Inc holds 6,978 shares of BMY stock, worth $323,430. This represents 0.33% of its overall portfolio holdings.
Number of Shares
6,978
Previous 6,970
0.11%
Holding current value
$323,430
Previous $394,000
7.87%
% of portfolio
0.33%
Previous 0.31%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,811Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$8.87 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.35 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.01 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.4 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.08 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $98.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...